Replies to post #72 on Auxilium Pharmaceuticals Inc. (AUXL)

[starbuxsux]

Auxilium Pharma confirms FDA approval for XIAFLEX for the treatment of Peyronie's disease

1:30 PM ET 12/6/13 | Briefing.com

Co announced that the FDA has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease (PD). XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy. XIAFLEX has already been approved in the U.S., EU, Canada and Australia for the treatment of adult Dupuytren's contracture (DC) patients with a palpable cord. XIAFLEX for the treatment of DC is marketed under the trade name XIAPEX in the EU.